Status:
COMPLETED
The Effect of Probiotics on Microbial Translocation and Inflammation in HIV-infected Patients
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
HIV
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objective: In this study the investigators aim at investigating: 1. probiotics ability to modulate the microbiome and microbial translocation, 2. if probiotics affect the level of cholesterol, trigl...
Eligibility Criteria
Inclusion
- age over 18
- confirmed HIV
- no HIV treatment
- cluster of differentiation 4+ cell count over 350
Exclusion
- antibiotic or probiotic in last 2 month
- drugs that influence gut motility
- diabetes
- Inflammatory bowel disease
- cancer
- autoimmune diseases
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02764684
Start Date
January 1 2015
End Date
September 1 2016
Last Update
October 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100